South African pharma tycoon Gus Attridge loses $15.8 million on Aspen stake
Aspen co-founder Gus Attridge loses $15.8 million in three weeks as drug stocks fall, cutting Aspen’s value below $2.6 billion.
South African pharma tycoon
South African pharma tycoon Stephen Saad loses $44 million from Aspen stake
Aspen Pharmacare shares slide 33 percent, cutting Stephen Saad’s stake by $44 million amid global pharma pressures.
South African pharma tycoon Gus Attridge loses $12 million from Aspen stake
Gus Attridge’s Aspen Pharmacare stake drops over $12 million as shares slide 9.45%, pushing market value below $3 billion.
South African pharma mogul Stephen Saad’s Aspen stake sinks under $360 million
Aspen Pharmacare CEO Stephen Saad loses $32 million in 13 days as stock slumps; his stake now worth under $360 million amid JSE sell-off.
South African pharma tycoon Stephen Saad’s Aspen stake falls below $400 million
Stephen Saad’s stake slips below $400 million as Aspen shares fall 5.2% dragging market cap under $3 billion.
South African tycoon Stephen Saad's Aspen opens regional headquarters in Saudi Arabia
Aspen’s investment comes amid a broader push to localize manufacturing, enhance drug supply chains, and develop regional talent.
South African pharma tycoon Gus Attridge loses $7 million from Aspen stake
Shares of Aspen Pharmacare plunged 5.44 percent in a week, wiping millions off co-founder Gus Attridge’s stake.